Evidence map›Paper›PMID 37407947›Full record

ArticleBMC microbiology2023

Diversity and characteristics of plant immunity-activating bacteria from Brassicaceae plants.

Hiroki Kaneko, Fuma Miyata, Mari Kurokawa, Kenji Hashimoto, Kazuyuki Kuchitsu, Toshiki Furuya

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hiroki KanekoDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, 2641, 278-8510, Chiba, Japan.
Fuma MiyataDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, 2641, 278-8510, Chiba, Japan.
Mari KurokawaDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, 2641, 278-8510, Chiba, Japan.
Kenji HashimotoDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, 2641, 278-8510, Chiba, Japan.
Kazuyuki KuchitsuDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, 2641, 278-8510, Chiba, Japan.
Toshiki FuruyaDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Yamazaki, Noda, 2641, 278-8510, Chiba, Japan. tfuruya@rs.tus.ac.jp.
Tokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroorganisms that activate plant immune responses are useful for application as biocontrol agents in agriculture to minimize crop losses. The present study was conducted to identify and characterize plant immunity-activating microorganisms in Brassicaceae plants.

resultsA total of 25 bacterial strains were isolated from the interior of a Brassicaceae plant, Raphanus sativus var. hortensis. Ten different genera of bacteria were identified: Pseudomonas, Leclercia, Enterobacter, Xanthomonas, Rhizobium, Agrobacterium, Pantoea, Rhodococcus, Microbacterium, and Plantibacter. The isolated strains were analyzed using a method to detect plant immunity-activating microorganisms that involves incubation of the microorganism with tobacco BY-2 cells, followed by treatment with cryptogein, a proteinaceous elicitor of tobacco immune responses. In this method, cryptogein-induced production of reactive oxygen species (ROS) in BY-2 cells serves as a marker of immune activation. Among the 25 strains examined, 6 strains markedly enhanced cryptogein-induced ROS production in BY-2 cells. These 6 strains colonized the interior of Arabidopsis plants, and Pseudomonas sp. RS3R-1 and Rhodococcus sp. RS1R-6 selectively enhanced plant resistance to the bacterial pathogens Pseudomonas syringae pv. tomato DC3000 and Pectobacterium carotovorum subsp. carotovorum NBRC 14082, respectively. In addition, Pseudomonas sp. RS1P-1 effectively enhanced resistance to both pathogens. We also comprehensively investigated the localization (i.e., cellular or extracellular) of the plant immunity-activating components produced by the bacteria derived from R. sativus var. hortensis and the components produced by previously isolated bacteria derived from another Brassicaceae plant species, Brassica rapa var. perviridis. Most gram-negative strains enhanced cryptogein-induced ROS production in BY-2 cells via the presence of cells themselves rather than via extracellular components, whereas many gram-positive strains enhanced ROS production via extracellular components. Comparative genomic analyses supported the hypothesis that the structure of lipopolysaccharides in the outer cell envelope plays an important role in the ROS-enhancing activity of gram-negative Pseudomonas strains.

conclusionsThe assay method described here based on elicitor-induced ROS production in cultured plant cells enabled the discovery of novel plant immunity-activating bacteria from R. sativus var. hortensis. The results in this study also suggest that components involved in the ROS-enhancing activity of the bacteria may differ depending largely on genus and species.

Indexed as

ArabidopsisBrassicaceaePlant DiseasesPlant ImmunityPseudomonas syringaeReactive Oxygen SpeciesReactive Oxygen SpeciesBiocontrolBrassicaceaeCultured plant cellsEndophyteInduced systemic resistancePlant immunityPrimingReactive oxygen species

Identifiers

PMID37407947
PMCPMC10320978
OpenAlexW4383225111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.